BDNF and depressive symptom measurement: Indeed, numerous studies have shown reduced serum levels of brain-derived neurotrophic factor (BDNF) in patients with MD compared to healthy controls (74–76), and evidence also exists to support renormalization of BDNF levels upon successful anti-depression interventions (74, 77).